Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

10,506articles mentioning drugs

58,393drug mentions

9,496distinct drugs extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

View all 9,496 drugs on one page

Articles mentioning drugs

10,506 articles · page 183 of 876

What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK

bmjph · abstract · 2025-07-22 · 8 matching annotations

93.3%

GLP-1RAs Glucagon-like peptide-1 receptor agonists Obesity

… challenge globally. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated significant efficacy in weight loss; however…

Novel biallelic NUP107 variants affect the nuclear pore complex and expand the clinical spectrum to include brain malformations

jmedgenet · abstract · 2025-07-21 · 8 matching annotations

91.9%

NUP107 end-stage renal disease

…ived cells. Our functional data support the conclusion that the NUP107 variants underlie the patient’s phenotype, thereby broadening t…

Clinical similarity in cost-comparison evaluations: a systematic review of current methods in NICE appraisals and the development of a framework for the formal assessment of clinical similarity

bmjopen · abstract · 2026-07-21 · 7 matching annotations

97.3%

ravulizumab crovalimab eculizumab paroxysmal nocturnal haemoglobinuria National Institute for Health and Care Excellence NICE

…bability of non-inferiority of crovalimab versus eculizumab and ravulizumab.Conclusions Interpretations of statistically non-significant IT…

Identification and management of genetic susceptibility to cancer: UK perspective

bmjonc · full text · 2026-07-20 · 7 matching annotations

99.4%

aspirin Tamoxifen raloxifene Olaparib CHEK2 Cancer

…in the UK due to insufficient evidence.The protective effect of aspirin in reducing colorectal cancer risk among individuals with Lynch…

E-055 Passive advancement of an aspiration catheter tip during mechanical thrombectomy predicts superior recanalization outcomes

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

92.0%

eTICI 2b-3 eTICI 2c-3 Piraeus Medical Route 92 Medical

…a branch point on subsequent angiography. Primary outcomes were eTICI 2b-3, eTICI 2c-3, and modified first pass effect (mFPE eTICI 2c-3). …

E-072 Reversible cerebrovascular vasoconstriction syndrome after carotid artery stenting

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

96.8%

aspirin milrinone clopidogrel verapamil ticagrelor carotid thrombosis ischemic stroke hyperperfusion syndrome RCVS DM

…irmed with carotid duplex. The patient was started on DAPT with aspirin, clopidogrel and subsequently underwent left ICA cervical segme…

E-085 Improving automated detection of medium vessel occlusions: the synergistic role of rapid LMVO and automated perfusion imaging

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

90.9%

Rapid LMVO Rapid LVO MUSC Stanford Royal Melbourne acute ischemic strokes MeVOs Medium Vessel Occlusions (MeVOs)

…ion rose from 23.9% (11/46) on CTA to 100% (46/46) after adding Rapid LMVO and CTP (p<0.0001). High detection rates were also achieved in …

E-093 Impact of postoperative timing of the middle meningeal artery embolization after surgical evacuation on clinical outcomes in chronic subdural hematoma: a post hoc analysis of the MEMBRANE trial

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

94.5%

n-butyl cyanoacrylate Zylox-Tonbridge Radical Aurenar Phantom Neuro Borvo chronic subdural hematoma (cSDH)Miami Clinical and Translational Science Institute National Institute of Health METIS Innovative+6 more

…Introduction Middle meningeal artery embolization (MMAE) using n-butyl cyanoacrylate has been demonstrated as an effective adjunct to surgical evacu…

E-101 Genotype-platelet reactivity discordance with verifynow PRU testing in point-of-care CYP2C19 testing for neuroendovascular procedures

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

99.1%

clopidogrel prasugrel ticagrelor Antiplatelet management

…function], *17 [gain-of-function]) and VerifyNow PRU testing on clopidogrel. Thromboelastography with platelet mapping was available in 26.…

E-107 Novel use of intravenous cangrelor in pediatric traumatic internal carotid artery reconstruction: a single-center case series

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

97.3%

cangrelor aspirin Pediatric traumatic cerebrovascular injury

…ee patients, our experience aligns with adult data and supports cangrelor’s feasibility as an adjunct or bridge in acute pediatric neuroi…

E-161 Pharmacologic rescue of central nervous system microcirculatory impairment

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

98.5%

Fasudil DCZ Gq-DREADD Aneurysmal subarachnoid hemorrhage Brain Aneurysm Foundation stroke NINDS aneurysmal SAH American Heart Association DCI+1 more

…n vessel lumen diameter and RBC flux in comparison to baseline. Fasudil treatment robustly rescues this contractile effect, with signif…

E-244 A drug-loaded flow diverting stent for localized delivery of milrinone to intracranial aneurysms

neurintsurg · abstract · 2026-07-19 · 7 matching annotations

99.4%

Milrinone milrinone-eluting PLGA-Milrinone Post-subarachnoid haemorrhage-induced (SAH) vasospasm

…l ischemia despite current endovascular and medical management. Milrinone is an effective phosphodiesterase-3 (PDE-3) inhibitor for vasod…